Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Intrinsic Value
Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. [ Read More ]
The intrinsic value of one Middle East Pharmaceutical Industries Company SJSC stock under the Base Case scenario is hidden SAR. Compared to the current market price of 133.4 SAR, Middle East Pharmaceutical Industries Company SJSC is hidden .
Valuation Backtest
Middle East Pharmaceutical Industries Company SJSC
Run backtest to discover the historical profit from buying and selling Middle East Pharmaceutical Industries Company SJSC stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Middle East Pharmaceutical Industries Company SJSC
Current Assets | 277.6m |
Cash & Short-Term Investments | 15.1m |
Receivables | 165.2m |
Other Current Assets | 97.4m |
Non-Current Assets | 167.3m |
Long-Term Investments | 1.3m |
PP&E | 119.1m |
Intangibles | 46.9m |
Current Liabilities | 113.2m |
Accounts Payable | 28m |
Accrued Liabilities | 17m |
Short-Term Debt | 50.3m |
Other Current Liabilities | 17.9m |
Non-Current Liabilities | 25.3m |
Long-Term Debt | 3.2m |
Other Non-Current Liabilities | 22.1m |
Earnings Waterfall
Middle East Pharmaceutical Industries Company SJSC
Revenue
|
338.4m
SAR
|
Cost of Revenue
|
-131.1m
SAR
|
Gross Profit
|
207.4m
SAR
|
Operating Expenses
|
-129.1m
SAR
|
Operating Income
|
78.2m
SAR
|
Other Expenses
|
-12.4m
SAR
|
Net Income
|
65.8m
SAR
|
Free Cash Flow Analysis
Middle East Pharmaceutical Industries Company SJSC
Profitability Score
Profitability Due Diligence
Middle East Pharmaceutical Industries Company SJSC's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Middle East Pharmaceutical Industries Company SJSC's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Middle East Pharmaceutical Industries Company SJSC's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Middle East Pharmaceutical Industries Company SJSC's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Middle East Pharmaceutical Industries Company SJSC
According to Wall Street analysts, the average 1-year price target for Middle East Pharmaceutical Industries Company SJSC is 109.14 SAR with a low forecast of 108.07 SAR and a high forecast of 112.35 SAR.
Shareholder Return
Price
Middle East Pharmaceutical Industries Company SJSC
Average Annual Return |
N/A
|
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -31% |
Market Capitalization | 2.7B SAR |
Shares Outstanding | 20 000 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Contact
IPO
Employees
Officers
The intrinsic value of one Middle East Pharmaceutical Industries Company SJSC stock under the Base Case scenario is hidden SAR.
Compared to the current market price of 133.4 SAR, Middle East Pharmaceutical Industries Company SJSC is hidden .